News About: Pharm. Industry
KPBMA runs association in emergency with next Chair Jung-Hee Lee and Acting Chairman Won-Il Gal
As Chairman Hee-Mok Won resigned his position, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association decided to temporarily run the association in emergency by Jung-Hee Lee, the next Chair, and Acting Chai...
AstraZeneca Korea appoints President Sang-Pyo Kim as CEO
AstraZeneca Korea(CEO/President Sang-Pyo Kim, http://www.astrazeneca.co.kr) announced appointment of Sang-Pyo Kim, the new president, as the CEO as of 1 February.
Before joining in AstraZeneca Korea, CEO/President Sa...
Celltrion meeting requirements for new IPO, getting closer to KOSPI market
As trying hard to go public in a securities market, Celltrion announced in its official notice on the 5th that the company was informed to meet all the requirements of Article 29 of the KOSPI listing regulations and A...
Pharma & Biotech industry expected to grow 17% in 2018
While the world’s economic growth rate is anticipated to rarely change at late 3%, the pharmaceutical & biotechnology industry is expected to largely grow 17% up as a new growing industry.
The Export-Import Bank of K...
U.S. FDA designates Hanmi Pharm’s LAPSGlucagon Analog as orphan drug
LAPSGlucagon Analog(HM15136) that Hanmi Pharm is developing as a congenital hyperinsulinemia treatment has been recognized as an orphan drug from the U.S. FDA on the 1st.
The Orphan Drug Designation program by the FD...
Yuhan Corporation acquires approval of clinical trial for cancer immunotherapy for first time in KoreaImmuneOncia(CEO Kwang-Ho Jung), a subsidiary of Yuhan Corporation, announced that the company has acquired approval of the Phase I clinical trial plan for IMC-011, a cancer immu...
|
GC Pharma’s ‘Perami Flu’ increases quadrupleAlong with the global record-breaking cold wave and flu(influenza), an injection-type flu treatment has attracted people as a new treatment option.
GC Pharma(CEO Eun-Cheol Huh)...
|
Total 15 products generated since Sewon Cellontech’ Chondron’s first approvalEven since Sewon Cellontech’s cartilage cell ‘Chondron’ acquired approval as the firs stem cell treatment in 2001, total 15 products had acquired approval as stem cell therapy u...
|
Government allows Korean pharmaceutical companies to manufacture foreign new drugs and orphan drugs under contract
New drugs and orphan drugs whose technology transferred to a Korean manufacturer if sold in other countries will now be available to manufacturer under contract even in Korea.
As the Pharmaceutical Affairs Law is rev...
One after another, KPBMA to find a person for its new chairman
At this point where it has been over 10 months since Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) Chairman Hee-Mok Won was appointed, the association has to find the ‘right person’ once again a...
